Task: Answer the multiple choice question.
Question: Which drug exhibits a 8.860\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COc1ccc(CCN2C(=O)CC(NNC(=O)c3ccccc3Br)C2=O)cc1OC
b. O=C(Nc1ccccn1)C(NS(=O)(=O)c1cccc2nsnc12)c1ccccc1
Answer: a. COc1ccc(CCN2C(=O)CC(NNC(=O)c3ccccc3Br)C2=O)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCN2C(=O)CC(NNC(=O)c3ccccc3Br)C2=O)cc1OC
COc1ccc(CCN2C(=O)CC(NNC(=O)c3ccccc3Br)C2=O)cc1OC
2-bromo-N'-[2,5-dioxo-1-[2-(4,5-dimethoxyphenyl)ethyl]pyrrolidin-3-yl]benzohydrazide